摘要
继发性甲状旁腺功能亢进症（SHPT）是慢性肾脏疾病（CKD）最常见的并发症之一。维生素D及其类似物是治疗SHPT的常用药物，充分了解低维生素D状态对CKD患者的危害，维生素D制剂治疗SHPT的药理机制及治疗过程中应该注意的问题，有助于临床医师合理应用此类药物，延缓SHPT发展为三发性甲状旁腺功能亢进症。
Secondary hyperparathyroidism（SHPT） is one of the most common complications in patients with chronic kidney disease（CKD）. Vitamin D and its analogues are the common agents for treatment of SHPT. It is necessary to familiarize with the hazard of hypovitaminosis D to CKD,pharmaceutical mechanism and the problems of vitamin D treatment involved in SHPT secondary to CKD. Clinicians can accordingly make good use of the pharmaceutical agents to retard SHPT to tertiary hyperparathyroidism.
出处
《国际内分泌代谢杂志》
2010年第1期23-25,28,共4页
International Journal of Endocrinology and Metabolism
